FIELD: medicine.
SUBSTANCE: biochip enabling diagnosing type I galactosemia is produced. Also, a method of using the produced biochip for detecting point mutations in GALT gene is offered. The given method involves a two-round multiplex PCR to produce a one-chained fluorescent marked DNA fragment; hybridisation on the biochip containing a set of oligonucleotides; analysis of the results.
EFFECT: invention extends the range of technological products used in diagnosing type I galactosemia.
3 cl, 34 dwg, 23 tbl, 6 ex
Authors
Dates
2011-07-10—Published
2009-10-27—Filed